机译:Kit Kit Kit突变和CD CD 117过表达是外阴黑色素瘤中更好的进展存活的标志物
Department of PathologyMassachusetts General Hospital and Harvard Medical SchoolBoston MA U.S.A;
Duke University Medical CenterDurham NC U.S.A;
Department of PathologyMassachusetts General Hospital and Harvard Medical SchoolBoston MA U.S.A;
University of Texas Southwestern Medical CenterDallas TX U.S.A;
Duke University Medical CenterDurham NC U.S.A;
Poznan University Medical Sciences and Greater Poland Cancer CenterPoznan Poland;
Department of Dermatology Melanoma UnitHospital Clínic de BarcelonaBarcelona Spain;
Duke University Medical CenterDurham NC U.S.A;
University of Arkansas for Medical SciencesLittle Rock AR U.S.A;
Department of MedicineUniversity of ChicagoIL U.S.A;
Department of Dermatology Melanoma UnitHospital Clínic de BarcelonaBarcelona Spain;
Hospital Universitari Germans Trias i PujolBarcelona Spain;
Medical University of GdanskGdansk Poland;
Center of Oncology M. Sklodowska‐Curie Memorial InstituteKrakow Poland;
Poznan University Medical Sciences and Greater Poland Cancer CenterPoznan Poland;
Department of PathologyMassachusetts General Hospital and Harvard Medical SchoolBoston MA U.S.A;
机译:Kit Kit Kit突变和CD CD 117过表达是外阴黑色素瘤中更好的进展存活的标志物
机译:默克尔细胞癌:KIT(CD117)表达的评估和未能证明C-KIT原癌基因中的活化突变-甲磺酸伊马替尼的治疗意义。
机译:恶性黑色素瘤中HER-2 / neu,c-Kit(CD117)和血管内皮生长因子(VEGF)过表达的免疫组织化学测定。
机译:优先事项之一:生存!-第三部分海军先进的生存物品更新个人生存装备
机译:小鼠骨髓中IL-33靶标的鉴定:血统(负功率)Sca-1(负功率)c-Kit(负功率)CD25(负功率)细胞已神秘化
机译:免疫组化测定恶性黑色素瘤中HER-2 / neu过表达没有预后价值而c-Kit(CD117)过表达则显示出潜在的治疗意义
机译:快速筛选CD117阳性胃肠道间质瘤中KIT和PDGFRA突变的微流控删除/插入分析:一种新的KIT突变的诊断应用和报告。